Your browser doesn't support javascript.
loading
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Santoni, Matteo; Massari, Francesco; Myint, Zin W; Iacovelli, Roberto; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Kucharz, Jakub; Buti, Sebastiano; Salfi, Alessia; Büttner, Thomas; De Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondrej; Grande, Enrique; Zucali, Paolo Andrea; Fornarini, Giuseppe; Bourlon, Maria T; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R; Pichler, Renate; Cattrini, Carlo; Büchler, Tomas; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Zakopoulou, Roubini; Caffo, Orazio; Procopio, Giuseppe; Bassanelli, Maria; Zampiva, Ilaria; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen; Vau, Nuno; Incorvaia, Lorena; Rebuzzi, Sara Elena; Roviello, Giandomenico; Zabalza, Ignacio Ortego; Rizzo, Alessandro; Mollica, Veronica.
Afiliação
  • Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.
  • Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia. Electronic address: fmassari79@gmail.com.
  • Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY.
  • Iacovelli R; Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Basso U; Oncology 3 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Kucharz J; Department of Uro-oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland.
  • Buti S; Medical Oncology Unit, University Hospital of Parma - Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Salfi A; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy.
  • Büttner T; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy.
  • Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Bourlon MT; Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Scagliarini S; UOC di Oncologia, Azienda Ospedaliera di Rilievo Nazionale Cardarelli di Napoli, Naples, Italy.
  • Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.
  • Aurilio G; Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Matrana MR; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA.
  • Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
  • Cattrini C; Department of Medical Oncology, "Maggiore della Carità" University Hospital, Novara, Italy.
  • Büchler T; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.
  • Seront E; Department of Medical Oncology, Centre Hospitalier de Jolimont, Belgium.
  • Calabrò F; Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Pinto A; Medical Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Berardi R; Department of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti delle Marche, Ancona, Italy.
  • Zgura A; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Mammone G; Department of Radiological, Oncological and Anatomo-Pathological Science, "Sapienza" University of Rome, Rome, Italy.
  • Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.
  • Atzori F; Unità di Oncologia Medica, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
  • Chiari R; UOC Oncologia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Italy.
  • Zakopoulou R; 2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Caffo O; Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy.
  • Procopio G; Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncologia Medica, Ospedale Maggiore di Cremona, Italy.
  • Bassanelli M; Medical Oncology 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Zampiva I; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
  • Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.
  • Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.
  • Mosca A; Oncology, Candiolo Cancer Institute, IRCCS-FPO, Torino, Italy.
  • Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India.
  • Vau N; Urologic Oncology, Champalimaud Clinical Center, Lisbon, Portugal.
  • Incorvaia L; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Rebuzzi SE; Ospedale San Paolo, Medical Oncology, Savona, Italy; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
  • Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
  • Zabalza IO; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Rizzo A; Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico "Don Tonino Bello", I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.
Clin Genitourin Cancer ; 21(5): e309-e319.e1, 2023 10.
Article em En | MEDLINE | ID: mdl-37062658
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article